CVE-2015-8531
UnknownEPSS 0.77%
Last modified
CVE-2015-8531 is a vulnerability of currently unknown severity. Cross-site scripting (XSS) vulnerability in IBM Security Access Manager for Web 8.0 before 8.0.1.3 IF4 and 9.0 before 9.0.0.1 IF1 allows remote attackers to inject arbitrary web script or HTML via a crafted URL.. EPSS estimates a 0.77% chance of exploitation in the next 30 days.
Description
Cross-site scripting (XSS) vulnerability in IBM Security Access Manager for Web 8.0 before 8.0.1.3 IF4 and 9.0 before 9.0.0.1 IF1 allows remote attackers to inject arbitrary web script or HTML via a crafted URL.
Metrics
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Ibm | Security Access Manager 9.0 Firmware | 9.0.0 |
| Ibm | Security Access Manager For Web 8.0 Firmware | 8.0.0.1 |
| Ibm | Security Access Manager For Web 8.0 Firmware | 8.0.0.2 |
| Ibm | Security Access Manager For Web 8.0 Firmware | 8.0.0.3 |
| Ibm | Security Access Manager For Web 8.0 Firmware | 8.0.0.5 |
| Ibm | Security Access Manager For Web 8.0 Firmware | 8.0.1 |
| Ibm | Security Access Manager For Web 8.0 Firmware | 8.0.1.0 |
| Ibm | Security Access Manager For Web 8.0 Firmware | 8.0.1.2 |
References
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2015-8531?
Cross-site scripting (XSS) vulnerability in IBM Security Access Manager for Web 8.0 before 8.0.1.3 IF4 and 9.0 before 9.0.0.1 IF1 allows remote attackers to inject arbitrary web script or HTML via a crafted URL.
How severe is CVE-2015-8531?
Severity scoring for CVE-2015-8531 is pending analysis. The EPSS model estimates a 0.77% probability of exploitation in the next 30 days.
How do I fix CVE-2015-8531?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2015-8531?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
